ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 5 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $10,518,149 | +10.6% | 486,726 | -0.9% | 5.74% | +12.6% |
Q3 2022 | $9,510,000 | +2.4% | 491,244 | +5.0% | 5.10% | -30.4% |
Q2 2022 | $9,290,000 | -35.1% | 467,795 | -2.5% | 7.32% | -20.8% |
Q1 2022 | $14,318,000 | +19.6% | 480,000 | -6.6% | 9.25% | +29.0% |
Q4 2021 | $11,973,000 | -13.8% | 514,082 | +15.5% | 7.17% | -6.2% |
Q3 2021 | $13,885,000 | +33.8% | 445,020 | +50.8% | 7.64% | +17.7% |
Q2 2021 | $10,381,000 | +72.9% | 295,080 | +73.2% | 6.49% | +32.0% |
Q1 2021 | $6,005,000 | -8.4% | 170,352 | -2.5% | 4.92% | +62.3% |
Q4 2020 | $6,556,000 | +60.4% | 174,791 | +42.7% | 3.03% | +55.8% |
Q3 2020 | $4,088,000 | -22.4% | 122,500 | -38.4% | 1.94% | -14.0% |
Q2 2020 | $5,266,000 | -2.6% | 198,800 | -39.8% | 2.26% | -10.6% |
Q1 2020 | $5,409,000 | -13.9% | 330,407 | +33.7% | 2.53% | -8.4% |
Q4 2019 | $6,283,000 | +24.4% | 247,178 | -2.1% | 2.76% | -1.5% |
Q3 2019 | $5,050,000 | -38.2% | 252,500 | -0.3% | 2.80% | -32.0% |
Q2 2019 | $8,167,000 | -6.0% | 253,327 | -6.1% | 4.12% | +8.3% |
Q1 2019 | $8,691,000 | +31.1% | 269,836 | -0.1% | 3.80% | +11.2% |
Q4 2018 | $6,627,000 | +23.4% | 270,146 | +65.8% | 3.42% | +14.3% |
Q3 2018 | $5,369,000 | – | 162,905 | – | 2.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |